EBSAM
Eubel Brady & Suttman Asset Management’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,147
| Closed | -$299K | – | 94 |
|
|
2023
Q2 | $299K | Buy |
8,147
+27
| +0.3% | +$991 | 0.04% | 76 |
|
|
2023
Q1 | $331K | Buy |
8,120
+12
| +0.1% | +$489 | 0.05% | 76 |
|
|
2022
Q4 | $415K | Buy |
8,108
+107
| +1% | +$5.48K | 0.07% | 76 |
|
|
2022
Q3 | $350K | Hold |
8,001
| – | – | 0.06% | 73 |
|
|
2022
Q2 | $419K | Hold |
8,001
| – | – | 0.08% | 59 |
|
|
2022
Q1 | $414K | Hold |
8,001
| – | – | 0.08% | 59 |
|
|
2021
Q4 | $472K | Hold |
8,001
| – | – | 0.09% | 58 |
|
|
2021
Q3 | $344K | Hold |
8,001
| – | – | 0.07% | 56 |
|
|
2021
Q2 | $290K | Sell |
8,001
-8,001
| -50% | -$290K | 0.03% | 165 |
|
|
2021
Q1 | $580K | Buy |
16,002
+9,601
| +150% | +$348K | 0.06% | 70 |
|
|
2020
Q4 | $236K | Hold |
6,401
| – | – | 0.06% | 71 |
|
|
2020
Q3 | $235K | Hold |
6,401
| – | – | 0.06% | 66 |
|
|
2020
Q2 | $209K | Hold |
6,401
| – | – | 0.05% | 71 |
|
|
2020
Q1 | $209K | Hold |
6,401
| – | – | 0.06% | 68 |
|
|
2019
Q4 | $251K | Buy |
6,401
+55
| +0.9% | +$2.16K | 0.07% | 69 |
|
|
2019
Q3 | $228K | Buy |
6,346
+7
| +0.1% | +$251 | 0.07% | 69 |
|
|
2019
Q2 | $275K | Buy |
6,339
+6
| +0.1% | +$260 | 0.08% | 64 |
|
|
2019
Q1 | $269K | Buy |
6,333
+6
| +0.1% | +$255 | 0.08% | 61 |
|
|
2018
Q4 | $276K | Buy |
6,327
+15
| +0.2% | +$654 | 0.09% | 59 |
|
|
2018
Q3 | $278K | Buy |
6,312
+6
| +0.1% | +$264 | 0.08% | 62 |
|
|
2018
Q2 | $229K | Sell |
6,306
-8
| -0.1% | -$291 | 0.07% | 63 |
|
|
2018
Q1 | $224K | Buy |
6,314
+7
| +0.1% | +$248 | 0.07% | 60 |
|
|
2017
Q4 | $228K | Sell |
6,307
-22
| -0.3% | -$795 | 0.07% | 68 |
|
|
2017
Q3 | $226K | Buy |
6,329
+33
| +0.5% | +$1.18K | 0.07% | 72 |
|
|
2017
Q2 | $211K | Buy |
6,296
+6
| +0.1% | +$201 | 0.06% | 73 |
|
|
2017
Q1 | $215K | Buy |
6,290
+53
| +0.8% | +$1.81K | 0.06% | 69 |
|
|
2016
Q4 | $203K | Buy |
6,237
+6
| +0.1% | +$195 | 0.06% | 72 |
|
|
2016
Q3 | $211K | Sell |
6,231
-4
| -0.1% | -$135 | 0.07% | 74 |
|
|
2016
Q2 | $220K | Buy |
+6,235
| New | +$220K | 0.07% | 69 |
|